Author details

Full Name

Mandy van Hoek

Affiliation

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37422864	IgG N-glycans are associated with prevalent and incident complications of type 2 diabetes.		2023
37834292	Apolipoprotein-CIII <i>O</i>-Glycosylation, a Link between <i>GALNT2</i> and Plasma Lipids.	Int J Mol Sci	2023
37798620	The (cost) effectiveness of a very low-energy diet intervention with the use of eHealth in patients with type 2 diabetes and obesity: study protocol for a randomised controlled non-inferiority trial (E-diet trial).		2023
36693768	Bariatric surgery in a patient with cystic fibrosis and diabetes: A case report.		2023
36926036	Four missense genetic variants in <i>CUBN</i> are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans.	Front Endocrinol (Lausanne)	2023
34645615	Plasma protein <i>N-</i>glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes.	BMJ Open Diabetes Res Care	2021
36644668	Breakfast partly restores the anti-inflammatory function of high-density lipoproteins from patients with type 2 diabetes mellitus.	Atheroscler Plus	2021
33854433	Effect of Liraglutide on Cardiometabolic Risk Profile in People with Coronary Artery Disease with or without Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.	Frontiers in Pharmacology	2021
34026735	Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry.	Front Chem	2021
33432548	Type 2 Diabetes Mellitus and Vertebral Fracture Risk.	Curr Osteoporos Rep	2021
33214188	Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria.	BMJ Open Diabetes Res Care	2020
32025877	Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study.	Acta Diabetol	2020
31958296	Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands.	BMJ Open Diabetes Res Care	2020
32349995	Association of the IgG <i>N</i>-glycome with the course of kidney function in type 2 diabetes.	BMJ Open Diabetes Res Care	2020
32152647	Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus.	Diabetologia	2020
32993159	Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation.	International Journal of Molecular Sciences	2020
32616483	Metformin and statin use associate with plasma protein <i>N</i>-glycosylation in people with type 2 diabetes.	BMJ Open Diabetes Res Care	2020
31814576	Adapt and adopt? The non-evidence based implementation of evidence-based guidelines.		2019
31632632	The effect of guideline revisions on vascular complications of type 2 diabetes.	Ther Adv Endocrinol Metab	2019
30251656	Plasma protein N-glycan signatures of type 2 diabetes.	Biochim Biophys Acta Gen Subj	2018
27787621	ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study.	Diabetologia	2017
28668296	IgG glycan patterns are associated with type 2 diabetes in independent European populations.	Biochim Biophys Acta Gen Subj	2017
28442299	The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review.	J Clin Lipidol	2017
28649285	Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes.	Diabetol Metab Syndr	2017
26575606	Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study.	Lancet Diabetes Endocrinol	2016
27117940	The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study.	Cardiovasc Diabetol	2016
25031086	Common variants in PCSK1 influence blood pressure and body mass index.	J Hum Hypertens	2015
26314712	Cardiovascular disease prevention: Mind the gap...		2015
24958070	A genetic variant in SLC6A20 is associated with Type 2 diabetes in white-European and Chinese populations.	Diabet Med	2014
22238593	A genome-wide association search for type 2 diabetes genes in African Americans.	PLoS One	2012
22479202	Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.	PLoS Genet	2012
21373834	Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons.	Diabetologia	2011
20581827	Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis.	Nat Genet	2010
20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Nat Genet	2010
20081857	Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.	Nat Genet	2010
20562194	Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve.	Am J Epidemiol	2010
19017754	Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.	Journal of Clinical Endocrinology and Metabolism	2009
19367320	Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes.	Eur J Hum Genet	2009
19636253	Evaluation of risk prediction updates from commercial genome-wide scans.	Genet Med	2009
19258437	Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism.	Diabetes	2009
19210142	Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.	Curr Med Res Opin	2009
18694974	Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study.	Diabetes	2008
17977935	High serum uric acid as a novel risk factor for type 2 diabetes.	Diabetes Care	2008
18496666	An RBP4 promoter polymorphism increases risk of type 2 diabetes.	Diabetologia	2008
18925945	Lack of association of two common polymorphisms on 9p21 with risk of coronary heart disease and myocardial infarction; results from a prospective cohort study.	BMC Med	2008
17623828	Risk of type 2 diabetes attributable to C-reactive protein and other risk factors.	Diabetes Care	2007
15721010	Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression.	Atherosclerosis	2005